ArticleAdvances in therapy2023

Correction to: Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab and Eculizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria: A Matching-Adjusted Indirect Comparison.

Raymond Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.